NCT05506865View on ClinicalTrials.gov

Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

July 31, 2016

Conditions
COPD
Interventions
DRUG

Indacaterol

Indacaterol, one inhales capsule, 150 mcgr, by dry powder dispositive

DRUG

Tiotropium

Tiotropium 18 mcgr, one inhaled capsule, by dry powder inhaler handihaler

Trial Locations (1)

14080

"Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas", Mexico City

All Listed Sponsors
lead

National Institute of Respiratory Diseases, Mexico

OTHER_GOV

NCT05506865 - Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure | Biotech Hunter | Biotech Hunter